We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RL icon
301
Ralph Lauren
RL
$23.7B
$605K 0.12%
3,220
+1,141
+55% +$189K
AGNC icon
302
AGNC Investment
AGNC
$12.7B
$601K 0.12%
+60,689
New +$585K
AMRC icon
303
Ameresco
AMRC
$1.34B
$600K 0.12%
+24,854
New +$557K
AOS icon
304
A.O. Smith
AOS
$8.46B
$599K 0.12%
+6,693
New +$552K
VRT icon
305
Vertiv
VRT
$105B
$596K 0.12%
+7,297
New +$458K
ERII icon
306
Energy Recovery
ERII
$429M
$594K 0.12%
37,624
+27,478
+271% +$437K
VCYT icon
307
Veracyte
VCYT
$3.78B
$590K 0.11%
+26,602
New +$649K
DIN icon
308
Dine Brands
DIN
$440M
$589K 0.11%
+12,671
New +$589K
HIG icon
309
Hartford Financial Services
HIG
$38.8B
$588K 0.11%
+5,702
New +$523K
ALHC icon
310
Alignment Healthcare
ALHC
$2.9B
$587K 0.11%
+118,444
New +$758K
MRNS
311
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$585K 0.11%
+64,721
New +$629K
PACB icon
312
Pacific Biosciences
PACB
$363M
$584K 0.11%
+155,769
New +$912K
PTGX icon
313
Protagonist Therapeutics
PTGX
$9.74B
$582K 0.11%
+20,131
New +$548K
TTEK icon
314
Tetra Tech
TTEK
$9.08B
$582K 0.11%
15,750
+2,655
+20% +$92K
CAR icon
315
Avis
CAR
$4.88B
$581K 0.11%
+4,747
New +$655K
ESI icon
316
Element Solutions
ESI
$9.19B
$581K 0.11%
+23,243
New +$540K
RIOT icon
317
Riot Platforms
RIOT
$7.57B
$577K 0.11%
+47,115
New +$614K
CTKB icon
318
Cytek Biosciences
CTKB
$552M
$576K 0.11%
+85,834
New +$679K
MBUU icon
319
Malibu Boats
MBUU
$572M
$570K 0.11%
+13,173
New +$604K
TPL icon
320
Texas Pacific Land
TPL
$23.7B
$566K 0.11%
2,937
+1,200
+69% +$206K
HMN icon
321
Horace Mann Educators
HMN
$2.1B
$560K 0.11%
+15,136
New +$537K
CC icon
322
Chemours
CC
$2.26B
$558K 0.11%
21,239
+1,501
+8% +$42.8K
RGA icon
323
Reinsurance Group of America
RGA
$16.1B
$556K 0.11%
2,885
-373
-11% -$65.1K
DASH icon
324
DoorDash
DASH
$92.6B
$555K 0.11%
+4,033
New +$475K
BWXT icon
325
BWX Technologies
BWXT
$15.7B
$554K 0.11%
5,394
-1,581
-23% -$141K
11 12
13
14 15

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.